REGISTER
SIGN IN
Neonatal IRT FEIA
MPIN: MP41076
Sign in to view price
Labsystems Diagnostics’ Neonatal IRT FEIA is a fluorometric enzyme immunoassay for the quantitative determination of human immuno reactive trypsinogen (IRT) from blood samples dried on filter paper as a primary test for screening of babies for cystic fibrosis (CF).
Ask for Quote
Labsystems Diagnostics’ Neonatal IRT FEIA is a fluorometric enzyme immunoassay for the quantitative determination of human immuno reactive trypsinogen (IRT) from blood samples dried on filter paper as a primary test for screening of babies for cystic fibrosis (CF).
Benefits
- Fluorescence detection provides high sensitivity
- Easy to perform, similar procedure than in TSH and 17-OHP kits
- Stable reagents
- Assay is compatible with Labsystems Diagnostics NS2400 automation system
Specification
- Neonatal IRT FEIA, 10 solid plates (96), 960 wells 6199831
- Neonatal IRT FEIA, 10 strip plates (12×8), 960 wells 6199832
Shipping Policy
Orders made at Medpick are initiated and processed for shipment upon receipt of request from the customer. Please note that our Shipping Services (Fee, Transportation, Loss or Damage of any shipment, etc.) are in accordance with the Seller\'s terms of Shipment.
Refund Policy
Please refer to Medpick Return Policy.
Cancellation / Return / Exchange Policy
Please refer to Medpick Return Policy.
Related products
-
Laboratory Infrastructure
Tissue-Tek® AutoTEC® a120
Say Goodnight to Overnight tissue processing The Tissue-Tek® Xpress® x120 Continuous Rapid Tissue Processor is a self-contained tissue processor employing microwave and vacuum infiltration techniques. The instrument performs automatic rapid processing (fixation, dehydration, clearing, and paraffin impregnation) of tissue specimens in preparation for histological study and examination.
SKU: MP40949 -
Laboratory Infrastructure
Neoscreen TSH
Congenital hypothyroidism (CH) is an endocrine disorder of newborns characterized by the decreased levels of thyroid hormones: thyroxine (T4) and triiodothyronine (T3) in periferal blood. In early perinatal period manifestations of CH are often non-specific, subtle or even non-existent [1-2]. However, the disease, if undiagnosed and untreated, leads to severe
SKU: MP40987 -
Laboratory Infrastructure
Neoscreen G6PD
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the most common human enzyme deficiency; an estimated 400 million people worldwide are affected by this enzymopathy (6). With regards to the demographics of G6PD deficiency, most of the affected individuals reside in Africa, the Middle East, and Southeast Asia. The G6PD enzyme catalyzes an oxidation/reduction reaction.
SKU: MP40989
